Consumer Defensive
Live Price
Offline$150.38
-0.12% today
1Y Change
-12.89%
Window
Jun 23, 2025 → Jun 1, 2026
Coverage: 236 bars · Jun 23, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Procter & Gamble Company (PG) is a Consumer Defensive stock with a market cap of $342.93B and listed on NYSE. The stock last traded around $150.38 and down 12.9% across the available one-year price window (Jun 23, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +0.3%, EPS growth of +7.9%, a dividend yield of 2.9%. What stands out right now is revenue +0.3%, EPS +7.9%, free cash flow -15.0% with operating margin 23.2% and ROIC 15.5%. The dividend matters to the case here, with a current yield around 2.9%. Valuation is more restrained than many high-expectation growth names at P/E 21.4 and price/sales 4.0. Stock Foundry combines PG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PG Max Drawdown
-16.10%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$76.1B
-5.1% YoY
FY Net Income
$14.3B
-3.0% YoY
Free Cash Flow
$15.6B
+14.9% YoY
Revenue Growth
+0.3%
EPS Growth
+7.9%
Gross Margin
50.3%
Net Margin
19.2%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 84.3B | 84.0B | 82.0B | 80.2B | 76.1B |
| Gross Profit | 43.1B | 43.2B | 39.2B | 38.0B | 39.0B |
| Operating Income | 20.5B | 18.5B | 18.1B | 17.8B | 18.0B |
| EBITDA | 23.9B | 22.6B | 21.8B | 21.2B | 20.9B |
| Net Income | 16.0B | 14.9B | 14.7B | 14.7B | 14.3B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 9.6B | 9.5B | 8.2B | 7.2B | 10.3B |
| Total Assets | 125.2B | 122.4B | 120.8B | 117.2B | 119.3B |
| Total Liabilities | 72.9B | 71.8B | 73.8B | 70.4B | 72.7B |
| Shareholder Equity | 52.0B | 50.3B | 46.8B | 46.6B | 46.4B |
| Total Debt | 35.5B | 33.4B | 35.4B | 32.3B | 32.8B |
| Net Debt | 25.9B | 23.9B | 27.2B | 25.1B | 22.6B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
18.4B
+9.9% YoY
Capital Expenditures
2.8B
+11.7% YoY
Free Cash Flow
15.6B
+14.9% YoY
Key ratios
Gross Margin
50.3%
Operating Margin
23.2%
Net Margin
19.2%
ROE
31.3%
Debt / Equity
0.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.